NAKAO KAZUWA has a total of 18 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are G2M CANCER DRUGS AG, ST GEORGES ENTPR LTD and COGNOSCI INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Measuring microorganism processes | |
#4 | Analysing materials | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Nakao Kazuwa | 17 |
#2 | Kitamura Hidetomo | 11 |
#3 | Yasoda Akihiro | 6 |
#4 | Hidetomo Nakao Kazuwa Yasoda A | 1 |
#5 | Kishimoto Ichiro | 1 |
#6 | Saito Yoshihiko | 1 |
Publication | Filing date | Title |
---|---|---|
EP3446711A1 | Composition for increasing body height | |
US2007197434A1 | Method of treating arthritis and promoting growth of articular chondrocytes | |
WO03035908A1 | Method of detecting hereditary factors for hypertension | |
BR0203172A | Pharmaceutical composition for achondroplasia |